Patients with rheumatoid arthritis (RA) experience a higher prevalence of periodontitis. This study aimed to examine the variation of periodontitis experienced with different serotypes suffered by RA patients and to examine the relationship between the different medications taken for RA that may influence this relationship. Two hundred and sixty RA and control participants underwent standardized periodontal examinations. Medical, serological and radiological (Sharp/van der Heijde) records were assessed. Functional status was assessed using the administered Health Assessment Questionnaire. Moreover, disease parameters, including disease activity (DAS28-ESR) and anti-citrullinated protein antibodies (ACPA) and rheumatoid factor (RF) seropositivity were evaluated. Periodontitis was higher in RA (71.54%) compared with controls (54.62%). The stage of periodontitis experienced by ACPA-positive participants were higher than APCA-negative participants. The probing pocket depth and recession experienced by RF-positive participants were higher than those who were RF-negative. RA participants on methotrexate had lower clinical attachment loss and lower periodontal probing depth compared with participants on a combination methotrexate and other disease-modifying antirheumatic drugs. Participants taking corticosteroids had lower gingival index scores. The association between seropositivity and the type of medications taken with periodontal health parameters in this group of patients suggests that both seropositivity and medications taken are important modifiers in the relationship between periodontitis and RA.

1. Tonetti, M. S., Jepsen, S., & Jin, L. (2017). Impact of the global burden of periodontal diseases on health, nutrition and wellbeing of mankind: A call for global action. Journal of Clinical Periodontology, 44(5), 456–462. https://doi.org/10.1111/jcpe.12732
2. Aletaha, D., Neogi, T., Silman, A. J., Funovits, J., Felson, D. T., Bingham, C. O., et al. (2010). 2010 rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis & Rheumatism, 62(9), 2569–2581. https://doi.org/10.1002/art.27584
3. Li, R., Tian, C., Postlethwaite, A., Jiao, Y., Pattanaik, D., Wei, D., et al. (2018). Rheumatoid arthritis and periodontal disease: What are the similarities and differences? International Journal of Rheumatic Diseases, 20(12), 1887–1901.
4. Sakthiswary, R., Radhika, S., Syahrul Sazliyana, S., & Abdul Wahab, A. (2019). Correlation of rheumatoid factor serotypes and computed tomography findings in rheumatoid arthritis related interstitial lung disease. Medicine & Health, 14(2), 203–211.
5. Koziel, J., Mydel, P., & Potempa, J. (2014). The link between periodontal disease and rheumatoid arthritis: An updated review. Current Rheumatology Reports, 16(3), 408. https://doi.org/10.1007/s11926-013-0408-5
6. Dissick, A., Redman, R. S., Jones, M., Rangan, B. V., Reimold, A., Griffiths, G. R., et al. (2010). Association of periodontitis with rheumatoid arthritis: A pilot study. Journal of Periodontology, 81, 223–230.
7. Fuggle, N. R., Smith, T. O., Kaul, A., & Sofat, N. (2016). Hand to mouth: A systematic review and meta-analysis of the association between rheumatoid arthritis and periodontitis. Frontiers in Immunology, 7, 80. https://doi.org/10.3389/fimmu.2016.00080
8. Jung, G., Han, J., Hwang, K., Park, C., Stathopoulou, P. G., & Fiorellini, J. P. (2018). Effects of conventional synthetic disease-modifying antirheumatic drugs on response to periodontal treatment in patients with rheumatoid arthritis. BioMed Research International, 1465402.
9. Äyräväinen, L., Leirisalo-Repo, M., Kuuliala, A., Ahola, K., Koivuniemi, R., Meurman, J. H., et al. (2017). Periodontitis in early and chronic rheumatoid arthritis: A prospective follow-up study in Finnish population. BMJ Open, 7(1), e011916.
10. Romero-Sánchez, C., Rodríguez, C., Santos-Moreno, P., Mesa, A. M., Lafaurie, G. I., Giraldo, Q. S., et al. (2017). Is the treatment with biological or non-biological DMARDs a modifier of periodontal condition in patients with rheumatoid arthritis? Current Rheumatology Reviews, 13(2), 139–151.
11. López, R., Scheutz, F., Errboe, M., & Baelum, V. (2007). Selection bias in case-control studies on periodontitis: A systematic review. European Journal of Oral Sciences, 115(5), 525–531.
12. Wacholder, S., McLaughlin, J. K., Silverman, D. T., & Mandel, J. S. (1992). Selection of controls in case-control studies. American Journal of Epidemiology, 135(9), 1029–1041.
13. Altman, R., Asch, E., Bloch, D., et al. (1986). Development of criteria for classification and reporting of osteoarthritis of the knee. Arthritis & Rheumatism, 29(8), 1039–1049.
14. Altman, R., Alarcón, G., Appelrouth, D., et al. (1990). The American College of Rheumatology criteria for hand osteoarthritis. Arthritis & Rheumatism, 33(6), 1601–1610.
15. Altman, R., Alarcón, G., Appelrouth, D., et al. (1991). The American College of Rheumatology criteria for hip osteoarthritis. Arthritis & Rheumatism, 34, 505–514.
16. O’Leary, T. J., Drake, R. B., & Naylor, J. E. (1972). The plaque control record. Journal of Periodontology, 43(1), 38.
17. Ainamo, J., & Bay, I. (1975). Problems and proposals for recording gingivitis and plaque. International Dental Journal, 25(4), 229–235.
18. Papapanou, P. N., Sanz, M., Buduneli, N., Dietrich, T., & Feres, M. (2018). Periodontitis: Consensus report of workgroup 2 of the 2017 World Workshop. Journal of Periodontology, 89(Suppl 1), S173–S182.
19. Landewé, R., & van der Heijde, D. (2005). Radiographic progression in rheumatoid arthritis. Clinical and Experimental Rheumatology, 23, S63–S68.
20. Hussein, H., Mustafa, R., Quek, K. F., Hassanudin, N. S., & Shahid, S. (2008). Cross-cultural adaptation and validation of a Malay Health Assessment Questionnaire. International Journal of Rheumatic Diseases, 11(3), 237–240.
21. Mikuls, T. R., Payne, J. B., Yu, F., et al. (2014). Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis. Arthritis & Rheumatism, 66(5), 1090–1100.
22. Rodríguez-Lozano, B., González-Febles, J., Garnier-Rodríguez, J. L., et al. (2019). Association between severity of periodontitis and clinical activity in rheumatoid arthritis patients. Arthritis Research & Therapy, 21, 27.
23. Nguyen, V. B., Nguyen, T. T., Huynh, N. C., et al. (2020). Relationship between periodontitis and rheumatoid arthritis in Vietnamese patients. Acta Odontologica Scandinavica, 78(7), 522–528.
24. Mohd-Dom, T. N., Abdul-Muttalib, K., Ayob, R., et al. (2013). Periodontal status and provision of periodontal services in Malaysia. Malaysian Journal of Public Health Medicine, 13(2), 38–47.
25. Nik-Azis, N. M., Mohd-Fadzilah, F., Mohd-Shahrir, M. S., et al. (2019). Impact of rheumatoid arthritis functional status on oral and periodontal health. Sains Malaysiana, 48(3), 645–652.
26. Payne, J. B., Golub, L. M., Thiele, G. M., & Mikuls, T. R. (2015). The link between periodontitis and rheumatoid arthritis: A periodontist’s perspective. Current Oral Health Reports, 2, 20–29.
27. Scott, D. L., Wolfe, F., & Huizinga, T. W. J. (2010). Rheumatoid arthritis. The Lancet, 376(9746), 1094–1108.
28. Choi, I. A., Kim, J., Kim, Y. M., et al. (2016). Periodontitis is associated with rheumatoid arthritis in Korean patients. Korean Journal of Internal Medicine, 31(5), 977–986.
29. Terao, C., Asai, K., Hashimoto, M., & Yamazaki, T. (2015). Association of periodontal disease with anti-citrullinated peptide antibody. Journal of Autoimmunity, 59, 85–90.
30. Potikuri, D., et al. (2012). Periodontal disease is higher in non-smoking rheumatoid arthritis patients. Annals of the Rheumatic Diseases, 71(9), 1541–1544.

31. González-Febles, J., et al. (2020). Association between periodontitis and anti-citrullinated protein antibodies in RA patients. Arthritis Research & Therapy, 22, 27.

32. Karapetsa, D., et al. (2021). Periodontitis in Italian patients with rheumatoid arthritis. Oral Diseases.

33. Eriksson, K., et al. (2016). Prevalence of periodontitis in rheumatoid arthritis patients. PLOS ONE, 11(5).

34. Svärd, A., et al. (2020). Anti-CCP antibodies in serum and saliva in RA patients. Clinical and Experimental Rheumatology, 38(4), 699–704.

35. Renvert, S., et al. (2020). Association between rheumatoid arthritis and periodontal disease. BMC Rheumatology, 4, 31.

36. Rahajoe, P. S., et al. (2020). Anti-citrullinated protein antibodies in periodontal inflammatory exudate. Journal of Clinical Periodontology, 47(5), 552–560.

37. Stefanov, L., et al. (2020). Serum anti-CCP antibodies in periodontitis associated with RA. Revmatologiia.

38. Gargiulo, A. V., et al. (1982). Identification of rheumatoid factor in periodontal disease. Journal of Periodontology, 53(9), 568–577.

39. Thé, J., & Ebersole, J. L. (1991). Rheumatoid factor distribution in periodontal disease. Journal of Clinical Immunology, 11(3), 132–142.

40. Rodríguez-Lozano, B., González-Febles, J., Garnier-Rodríguez, J. L., Dadlani, S., Bustabad-Reyes, S., Sanz, M., et al. (2019). Association between severity of periodontitis and clinical activity in rheumatoid arthritis patients: A case-control study. Arthritis Research & Therapy, 21, 27. https://doi.org/10.1186/s13075-019-1808-z
41. Nguyen, V. B., Nguyen, T. T., Huynh, N. C., Le, T. A., & Hoang, H. T. (2020). Relationship between periodontitis and rheumatoid arthritis in Vietnamese patients. Acta Odontologica Scandinavica, 78(7), 522–528. https://doi.org/10.1080/00016357.2020.1747635
42. Mohd-Dom, T. N., Abdul-Muttalib, K., Ayob, R., Lan, Y. S., Mohd-Asadi, A. S., Abdul-Manaf, M. R., et al. (2013). Periodontal status and provision of periodontal services in Malaysia: Trends and way forward. Malaysian Journal of Public Health Medicine, 13(2), 38–47.
43. Nik-Azis, N. M., Mohd-Fadzilah, F., Mohd-Shahrir, M. S., Baharin, B., & Mohd, N. (2019). Impact of rheumatoid arthritis functional status on oral and periodontal health in a multi-ethnic population. Sains Malaysiana, 48(3), 645–652.
44. Payne, J. B., Golub, L. M., Thiele, G. M., & Mikuls, T. R. (2015). The link between periodontitis and rheumatoid arthritis: A periodontist’s perspective. Current Oral Health Reports, 2, 20–29. https://doi.org/10.1007/s40496-014-0038-3
45. Scott, D. L., Wolfe, F., & Huizinga, T. W. J. (2010). Rheumatoid arthritis. The Lancet, 376(9746), 1094–1108. https://doi.org/10.1016/S0140-6736(10)60826-4
46. Choi, I. A., Kim, J., Kim, Y. M., et al. (2016). Periodontitis is associated with rheumatoid arthritis: A study with longstanding rheumatoid arthritis patients in Korea. Korean Journal of Internal Medicine, 31(5), 977–986. https://doi.org/10.3904/kjim.2015.202
47. Terao, C., Asai, K., Hashimoto, M., & Yamazaki, T. (2015). Significant association of periodontal disease with anti-citrullinated peptide antibody in a Japanese healthy population (The Nagahama study). Journal of Autoimmunity, 59, 85–90. https://doi.org/10.1016/j.jaut.2015.03.002
48. Potikuri, D., Dannana, K. C., Kanchinadam, S., et al. (2012). Periodontal disease is significantly higher in non-smoking treatment-naive rheumatoid arthritis patients. Annals of the Rheumatic Diseases, 71(9), 1541–1544. https://doi.org/10.1136/annrheumdis-2011-200380
49. González-Febles, J., Rodríguez-Lozano, B., Sánchez-Piedra, C., et al. (2020). Association between periodontitis and anti-citrullinated protein antibodies in rheumatoid arthritis patients. Arthritis Research & Therapy, 22, 27. https://doi.org/10.1186/s13075-020-2121-6
50. Karapetsa, D., Consensi, A., Castagnoli, G., et al. (2021). Periodontitis in Italian patients with established rheumatoid arthritis: A cross-sectional study. Oral Diseases. Advance online publication. https://doi.org/10.1111/odi.13819
51. Eriksson, K., Nise, L., Kats, A., et al. (2016). Prevalence of periodontitis in patients with established rheumatoid arthritis: A Swedish population-based case-control study. PLOS ONE, 11(5), e0155956. https://doi.org/10.1371/journal.pone.0155956
52. Svärd, A., Renvert, S., Sanmartin Berglund, J., Persson, G. R., & Söderlin, M. K. (2020). Antibodies to citrullinated peptides in serum and saliva in patients with rheumatoid arthritis and their association to periodontitis. Clinical and Experimental Rheumatology, 38(4), 699–704.
53. Renvert, S., Berglund, J. S., Persson, G. R., & Söderlin, M. K. (2020). The association between rheumatoid arthritis and periodontal disease in a population-based cross-sectional case-control study. BMC Rheumatology, 4, 31. https://doi.org/10.1186/s41927-020-00129-4
54. Rahajoe, P. S., de Smit, M., Schuurmans, G., et al. (2020). Increased IgA anti-citrullinated protein antibodies in periodontal inflammatory exudate. Journal of Clinical Periodontology, 47(5), 552–560. https://doi.org/10.1111/jcpe.13277
55. Stefanov, L., Bolyarova-Konova, T., Kolarov, Z., Pavlova, P., & Ivanova, M. (2020). Serum anti-CCP antibodies in periodontitis associated with rheumatoid arthritis. Revmatologiia (Bulgaria), 28(4), 3–18.
56. Gargiulo, A. V., Robinson, J., Toto, P. D., & Gargiulo, A. W. (1982). Identification of rheumatoid factor in periodontal disease. Journal of Periodontology, 53(9), 568–577. https://doi.org/10.1902/jop.1982.53.9.568
57. Thé, J., & Ebersole, J. L. (1991). Rheumatoid factor distribution in periodontal disease. Journal of Clinical Immunology, 11(3), 132–142.
58. Thé, J., & Ebersole, J. L. (1996). Rheumatoid factor from periodontitis patients cross-reacts with epitopes on oral bacteria. Oral Diseases.
59. Harrold, L. R., Harrington, J. T., Curtis, J. R., et al. (2012). Prescribing practices in a US cohort of rheumatoid arthritis patients before and after ACR recommendations. Arthritis & Rheumatism, 64(3), 630–638. https://doi.org/10.1002/art.33366
60. Gibofsky, A., Palmer, W. R., Goldman, J. A., et al. (2006). Real-world utilization of DMARDs and biologics in rheumatoid arthritis. Current Medical Research and Opinion, 22, 169–183.
61. Abdul Razak, S., Makmor-Bakry, M., & Md Redzuan, A. (2018). Management of rheumatoid arthritis: Special considerations for biologic DMARDs. Asian Journal of Pharmaceutical and Clinical Research, 11(11).
62. Savioli, C., Ribeiro, A. C., Fabri, G. M., et al. (2012). Persistent periodontal disease hampers anti-TNF treatment response in rheumatoid arthritis. Journal of Clinical Rheumatology, 18(4), 180–184. https://doi.org/10.1097/RHU.0b013e31825f2f34
63. Markitziu, A., Zafiropoulos, G., de Jacoby, L. F., & Pisanty, S. (1990). Periodontal alterations in patients with pemphigus vulgaris taking steroids. Journal of Clinical Periodontology, 17(4), 228–232.
64. Wee, A. S., Mohamed Said, M. S. B., & Md, A. B. (2016). Medication adherence status among rheumatoid arthritis patients. International Journal of Pharmacy and Pharmaceutical Sciences, 8(7), 317–321.
65. Eke, P. I., Page, R. C., Wei, L., Thornton-Evans, G., & Genco, R. J. (2012). Update of the case definitions for population-based surveillance of periodontitis. Journal of Periodontology, 83(12), 1449–1454. https://doi.org/10.1902/jop.2012.110664